Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan flag Japan · Delayed Price · Currency is JPY
4,075.00
+5.00 (0.12%)
Aug 25, 2026, 3:30 PM JST

Kissei Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
16,89115,61014,44913,68016,507
Depreciation & Amortization
4,6444,6154,2544,1093,730
Loss (Gain) From Sale of Assets
-7013,110-80-6335
Loss (Gain) From Sale of Investments
-17,376-11,999-9,119-13,133-16,161
Other Operating Activities
-3,061-4,427-1,893-5,799-2,672
Change in Accounts Receivable
-1,929-974-5,86327250
Change in Inventory
-5421,316-3,480-3,8101,130
Change in Accounts Payable
2,059-291275513-3,804
Change in Other Net Operating Assets
-1,470-439-220-2,2032,518
Operating Cash Flow
-1,4856,521-1,677-6,6791,533
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-4,883-4,507-1,201-2,103-1,489
Sale of Property, Plant & Equipment
3,3795191757823
Sale (Purchase) of Intangibles
-753-523-632-444-430
Investment in Securities
19,94313,0919,50213,03116,391
Other Investing Activities
-188-3,627844-4,564-3,741
Investing Cash Flow
17,5004,9528,6906,00110,776

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
170170---
Total Debt Issued
170170---
Short-Term Debt Repaid
-200-230-150-150-90
Long-Term Debt Repaid
-----13
Total Debt Repaid
-200-230-150-150-103
Net Debt Issued (Repaid)
-30-60-150-150-103
Repurchase of Common Stock
-5,217-5,293-6,000--
Common Dividends Paid
-4,841-3,801-3,722-3,135-2,536
Other Financing Activities
-167-171-134-135-117
Financing Cash Flow
-10,255-9,325-10,006-3,420-2,756

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
5227-3-214
Miscellaneous Cash Flow Adjustments
-96-1-1-
Net Cash Flow
5,8122,271-2,997-4,1209,557

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-6,3682,014-2,878-8,78244
Free Cash Flow Growth
-----
Free Cash Flow Margin
-6.54%2.28%-3.81%-13.01%0.07%
Free Cash Flow Per Share
-153.2246.17-63.59-190.440.95
Levered Free Cash Flow
82.752,448200.38-7,6543,843
Unlevered Free Cash Flow
100.252,461211.63-7,6413,858

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
2922182023
Cash Income Tax Paid
3,3634,3571,8345,6992,567
Change in Working Capital
-1,882-388-9,288-5,47394